Perpetuating fears: Bias against the null hypothesis in fetal safety of drugs as expressed in scientific citations

Journal of Population Therapeutics and Clinical Pharmacology

Volumn 18, Issue 1, 2011, Pages

  Koren, Gideon ^a,b   Nickel, Cheri ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

ACE inhibitors; Bendectin ; Benzodiazepines; Bias against the null; Citation impact; Congenital malformations; Oral contraceptives; Paroxetine; Statins

Indexed keywords

BENDECTIN; BENZODIAZEPINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYLAMINE PLUS PYRIDOXINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL CONTRACEPTIVE AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BIRTH DEFECT; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DRUG SAFETY; FEAR; FETUS MALFORMATION; FETUS RISK; HUMAN; HYPOCALVARIA; KIDNEY INJURY; MORNING SICKNESS; NULL HYPOTHESIS; PREGNANCY TERMINATION; SCIENTIFIC LITERATURE; SYSTEMATIC ERROR; TERATOGENICITY;

EID: 79959828297     PISSN: 17106222     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998;338:1128-1137.
2. Einarson TR, Leeder SJ, Koren G. A method for meta-analysis of epidemiological studies. Pharmacoepidemiol 1988;22:813-823.
3. Wilms LR, Tseng AL, Wighardt S, Einarson TR, Koren G. Fetal genital effects of firsttrimester sex hormone exposure: A metaanalysis. Obstet Gynecol 1995;85:141-149.
4. O'Brien L, Einarson TR, Sarkar M, Einarson A, Koren G. Does paroxetine cause cardiac malformations? J Obstet Gynaecol Can 2008;30:696-701.
5. Dolovich LR, Addis A, Vaillancourt R, Power B, Koren G. Benzodiazepine use in pregnancy and major malformations or oral cleft: metaanalysis of cohort and case-control studies. BMJ 1998;317:839-843.
6. Koren G. Bias against the null hypothesis in maternal-fetal pharmacology and toxicology. Clin Pharmacol Ther 1997;62:1-5.
7. Koren G, Graham K, Shear H, Einarson T. Bias against the null hypothesis: The reproductive hazards of cocaine. Lancet 1989;2:1440-1442.
8. Koren G, Klein N. Bias against negative studies in newspaper reports of medical research. JAMA 1991;266:1824-1826.
9. Nora AH. Editorial: Can the pill cause birth defects? N Engl J Med 1974;291:731-732.
10. Neutel CI, Johansen HL. Measuring drug effectiveness by default: the case of Bendectin. Can J Public Health 1995;86:66-70.
11. Laegreid L, Olegard R, Wahlstrom J, Conradi N. Abnormalities in children exposed to benzodiazepines in utero. Lancet 1987;1:108-109.
12. Einarson A, Selby P, Koren G. Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation. Can Fam Physician 2001;47:489-490.
13. Edison RJ, Muenke M. Central nervous system and limb anomalies in case reports of firsttrimester statin exposure. N Engl J Med 2004;350:1579-1582.
14. Kazmin A, Garcia-Bournissen F, Koren G. Risks of statin use during pregnancy: a systematic review. J Obstet Gynaecol Can 2007;29:906-908.
15. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-2451.
16. Tabacova S, Little R, Tsong Y, Vega A, Kimmel CA. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 2003;12:633-646.
17. Lennestal R, Otterblad Olausson P, Kallen B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 2009;65:615-625.
18. Jacqz-Aigrain E, Koren G. Effects of drugs on the fetus. Semin Fetal NeonatalMed 2005;10:139-47.
19. Greenberg SA. How citation distortions create unfounded authority: analysis of a citation network. BMJ 2009;339:b2680 (doi:10.1136/bmj.b2680)
20. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006;295:499-507.